EA200501848A1 - Фармацевтическая композиция, обладающая церебровазодилатирующей и ноотропной активностью - Google Patents

Фармацевтическая композиция, обладающая церебровазодилатирующей и ноотропной активностью

Info

Publication number
EA200501848A1
EA200501848A1 EA200501848A EA200501848A EA200501848A1 EA 200501848 A1 EA200501848 A1 EA 200501848A1 EA 200501848 A EA200501848 A EA 200501848A EA 200501848 A EA200501848 A EA 200501848A EA 200501848 A1 EA200501848 A1 EA 200501848A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
pharmaceutical composition
piracetam
vinpocetine
cerebrovododilatlating
Prior art date
Application number
EA200501848A
Other languages
English (en)
Other versions
EA009666B1 (ru
Original Assignee
Закрытое Акционерное Общество "Канонфарма Продакшн"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое Акционерное Общество "Канонфарма Продакшн" filed Critical Закрытое Акционерное Общество "Канонфарма Продакшн"
Publication of EA200501848A1 publication Critical patent/EA200501848A1/ru
Publication of EA009666B1 publication Critical patent/EA009666B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к области химико-фармацевтической промышленности, конкретно к фармацевтической композиции винпоцетина и пирацетама в виде твердой лекарственной формы, обладающей церебровазодилатирующей и ноотропной активностью. Предложена композиция винпоцетина и пирацетама в качестве активных ингредиентов и фармацевтически приемлемых носителей. Содержание активных веществ в композиции: винпоцетина 0,0045-0,0150 г и пирацетама 0,36-1,2 г. Данная композиция является эффективной в терапевтическом лечении вследствие широких возможностей варьирования соотношения между активными компонентами.
EA200501848A 2003-11-03 2004-10-29 Фармацевтическая композиция, обладающая церебровазодилатирующей и ноотропной активностью EA009666B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2003132049/15A RU2262931C2 (ru) 2003-11-03 2003-11-03 Фармацевтическая композиция, обладающая церебровазодилатирующей и ноотропной активностью
PCT/RU2004/000428 WO2005041952A1 (fr) 2003-11-03 2004-10-29 Composition pharmaceutique possedant une activite cerebrale vasodilatatrice et nootropique

Publications (2)

Publication Number Publication Date
EA200501848A1 true EA200501848A1 (ru) 2006-06-30
EA009666B1 EA009666B1 (ru) 2008-02-28

Family

ID=34545985

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501848A EA009666B1 (ru) 2003-11-03 2004-10-29 Фармацевтическая композиция, обладающая церебровазодилатирующей и ноотропной активностью

Country Status (3)

Country Link
EA (1) EA009666B1 (ru)
RU (1) RU2262931C2 (ru)
WO (1) WO2005041952A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111297818A (zh) * 2020-04-02 2020-06-19 常州制药厂有限公司 一种高载药量吡拉西坦片剂组合物及其制备方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2359669C1 (ru) * 2007-10-17 2009-06-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Фармацевтическая композиция в форме раствора для инъекций, обладающая церебровазодилатирующей и ноотропной активностью, и способ ее получения
WO2011055383A2 (en) 2009-11-06 2011-05-12 Lyka Labs Limited Intranasal delivery to improve the performance of children suffering from dyslexia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201674B (en) * 1987-08-26 1990-12-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition suitable for curing autoimmune-type leukoencephalomyelitic diseases e.g. sclerosis multiplex
JP2503571B2 (ja) * 1988-02-26 1996-06-05 武田薬品工業株式会社 脳循環代謝改善剤
RU2126250C1 (ru) * 1997-10-20 1999-02-20 Ставропольская государственная медицинская академия Способ лечения психопатологических синдромов пограничного уровня сосудисто- склеротического генеза
UA57813C2 (ru) * 2000-06-02 2003-07-15 Закрите Акціонерне Товариство "Фармацевтична Фірма "Дарниця" Лекарственный препарат винпоцетина для улучшения мозгового кровообращения
UA55983A (ru) * 2002-08-07 2003-04-15 Товариство З Обмеженою Відповідальністю Науково-Виробниче Об'Єднання "Фарматрон" Церебропротекторное и ноотропное лекарственное средство "ноотрил" в таблетках с оболочкой

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111297818A (zh) * 2020-04-02 2020-06-19 常州制药厂有限公司 一种高载药量吡拉西坦片剂组合物及其制备方法

Also Published As

Publication number Publication date
RU2003132049A (ru) 2005-04-20
WO2005041952A1 (fr) 2005-05-12
EA009666B1 (ru) 2008-02-28
RU2262931C2 (ru) 2005-10-27

Similar Documents

Publication Publication Date Title
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
EA200801492A1 (ru) Фармацевтическое применение замещенных амидов
HUP0102039A2 (hu) Albuminnal stabilizált paclitaxel alkalmazása tömör tumorok kezelésére szolgáló gyógyszerkészítmények előállítására, és a kapott gyógyszerkészítmények
ATE482747T1 (de) Neue amide derivate und deren pharmazeutische verwendungen
DE60143360D1 (de) Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
TW200501947A (en) Stabilized pharmaceutical composition comprising an amorphous active substance
EP2392322A3 (en) Dosing regimes for trans-clomiphene
DE602004018735D1 (de) Argon enthaltendes Arzneimittel zum Inhalieren und dessen Verwendung zur Behandlung von Neurotoxizität
DE60118956D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
HUP0400553A2 (hu) Gyógyászati készítmények
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
EA200501848A1 (ru) Фармацевтическая композиция, обладающая церебровазодилатирующей и ноотропной активностью
BE2016C017I2 (ru)
SE0000303D0 (sv) Novel compounds
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
EA200501591A1 (ru) Фармацевтическая комбинация для лечения мышечной спастичности и/или боли
RU2001124020A (ru) Состав для лечения ожогов
ATE259778T1 (de) Nicht-hygroskopische salze aktiver inhaltsstoffe, die therapeutische und/oder ernährungsphysiologische eigenschaften haben und oral verabreichbare zusammensetzungen, die diese enthalten
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
MXPA04006457A (es) Alcanosulfonamidas novedosas como antagonistas de endotelina.
EA200201064A3 (ru) Твердая лекарственная форма тербинафина гидрохлорида

Legal Events

Date Code Title Description
FA9A Withdrawal of a eurasian application
NF9A Restoration of lapsed right to a eurasian application

Designated state(s): AM AZ BY KZ KG MD TJ TM RU

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ RU

NF4A Restoration of lapsed right to a eurasian patent

Designated state(s): AZ BY KZ RU